SCHEMBL5035444

SCHEMBL5035444

Brc1ccccc1C(Cc1cccnc1)c1cccnc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.45
SLC6A4 P31645 2/20 0.45
SLC6A3 Q01959 2/20 0.45
CFTR P13569 1/20 0.45
GOPC Q9HD26 1/20 0.45
KCNA5 P22460 4/20 0.44
KCNH2 Q12809 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
CHRM1 P11229 1/20 0.41
FDPS P14324 1/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
TSHR P16473 1/20 0.41
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL884430 0.81 KCNA5 (0.61) SLC6A2SLC6A4SLC6A3CFTRGOPC
SCHEMBL5038329 0.80 KCNA5 (0.62) SLC6A2SLC6A4SLC6A3CFTRGOPC
SCHEMBL31570747 0.79 SLC6A2 (0.66) SLC6A2SLC6A4SLC6A3CFTRGOPC
SCHEMBL31570740 0.78 GAA (0.55) SLC6A2SLC6A4SLC6A3CFTRGOPC
SCHEMBL2062646 0.75 KCNA5 (0.65) SLC6A2SLC6A4SLC6A3CFTRGOPC
SCHEMBL884905 0.74 KCNA5 (0.51) SLC6A2SLC6A4SLC6A3CFTRGOPC
SCHEMBL11737361 0.73 GAA (0.66) SLC6A2SLC6A4SLC6A3CFTRGOPC
SCHEMBL9591930 0.73 SMN1; SMN2 (0.53) SLC6A2SLC6A4SLC6A3CFTRGOPC
SCHEMBL2063857 0.73 KCNA5 (0.47) SLC6A2SLC6A4SLC6A3CFTRGOPC
SCHEMBL11798962 0.73 SMN1; SMN2 (0.56) SLC6A2SLC6A4SLC6A3CFTRGOPC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940406-A2 POTASSIUM CHANNEL INHIBITORS Merck and Co., Inc. (US) 2008-07-09 EP disclosed
WO-2007050348-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2007-05-03 WO disclosed